[Benzonidazole: one of the rare treatment for Chagas disease].

C, Coilliot; M, Rouault; A, Wolf; C, Boulliat; C, Beranger; K, Gaillard; M, Oliver

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 2011

Data sources: Europe PubMed Central

[Benzonidazole: one of the rare treatment for Chagas disease].

descriptionPublicationkeyboard_double_arrow_right Article 06 Jun 2011 French Journal:Medecine tropicale : revue du Corps de sante colonial, volume 71 (issn: 0025-682X,

Copyright policy )

Authors: C, Coilliot; M, Rouault; A, Wolf; C, Boulliat; C, Beranger; K, Gaillard; M, Oliver;

pmid: 21585085

[Benzonidazole: one of the rare treatment for Chagas disease].

- Summary
- Subjects
- Metrics

Abstract

Benznidazole is indicated in the treatment of Chagas' disease, which is endemic in Latin America. However, it has numerous adverse effects and is effective only at certain disease stages. Because of these drawbacks and the appearance of resistance to benzinidazole, there is ongoing research for alternative therapeutic strategies and new drugs.

Keywords

Nitroimidazoles, Humans, Chagas Disease, Trypanocidal Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average